Few with type 2 diabetes receive guideline-recommended CKD screening
Jul 01, 2024
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening
Timing of metformin important in metformin-treated type 2 diabetes
Jun 21, 2024
Glucose lowering is greater when metformin is given before rather than with enteral glucose; this is also linked to greater GLP-1 response.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Vitamin D suggested for children, seniors, those with high-risk prediabetes
Jun 10, 2024
No evidence was seen to support routine 25(OH)D screening in the general population.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Men face more diabetes complications than women
May 17, 2024
The findings were independent of diabetes duration over a 10-year period.
Healthful plant-based diet may lower risk for Type 2 diabetes
Jan 22, 2024
The association with a lower risk for T2DM was partially mediated by lower BMI, lower waist circumference and lower HbA1c and triglycerides.
Mortality reduced with adherence to low-carb diet in type 2 diabetes
Mar 24, 2023
Lower mortality was seen with increases in total, vegetable and healthy low-carbohydrate diet scores.
Racial disparity seen in initiation of newer diabetes meds
Feb 01, 2022
Significantly lower rates of initiation were seen in Black and American Indian or Alaskan Native individuals.
Consensus statement defines remission of type 2 diabetes
Sep 07, 2021
Remission is defined as HbA1c <6.5% for at least three months after cessation of glucose-lowering pharmacotherapy.